Cambridge Investment Research Advisors, Inc. Vaxart, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$2.09 - $4.5 $22,638 - $48,744	10,832 New	10,832 $23,000
Q2 2022 Jul 13, 2022	SELL	$2.7 - $5.28 $71,928 - $140,659	-26,640 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.29 - $6.64 $1,381 - $2,138	322 Added 1.22%	26,640 $134,000
Q4 2021 Feb 03, 2022	BUY	$5.77 - $7.96 $151,854 - $209,491	26,318 New	26,318 $165,000
Q2 2021 Aug 10, 2021	SELL	$5.06 - $10.78 $166,732 - $355,211	-32,951 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.64 - $23.33 $125,123 - $517,576	22,185 Added 206.07%	32,951 $199,000
Q4 2020 Feb 04, 2021	SELL	$3.5 - $7.98 $33,215 - $75,730	-9,490 Reduced 46.85%	10,766 $61,000
Q3 2020 Oct 29, 2020	SELL	$4.78 - $16.97 $40,477 - $143,701	-8,468 Reduced 29.48%	20,256 $134,000
Q2 2020 Jul 27, 2020	BUY	$1.68 - $8.85 $48,256 - $254,207	28,724 New	28,724 $254,000

Others Institutions Holding VXRT

# of Institutions

107

Shares Held

37.7M

Call Options Held

188K

Put Options Held

180K

Sio Capital Management, LLC New York, NY

13.6M
Shares

$9.25 Million
6.11% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$6.85 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.97M
Shares

$2.7 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.54M
Shares

$1.73 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.77M
Shares

$1.21 Million
0.0% of portfolio

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account